FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Etomidate Injection
Status: Currently in Shortage
»Date first posted: 04/10/2020
»Therapeutic Categories: Anesthesia

Expand all

AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.) (Revised 05/05/2020)

Company Contact Information:
888-238-7880

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2 mg/mL, 10 mL vial (NDC 55150-221-10) Currently backordered Present shipment 2nd week of May 2020, next shipment mid- to late-June 2020 Demand increase for the drug
2 mg/mL, 20 mL vial (NDC 55150-222-10) Currently backordered Present shipment 2nd week of May 2020, next shipment mid- to late-June 2020 Demand increase for the drug

Gland Pharma (Reverified 05/11/2020)

Company Contact Information:
Athenex: 855-273-0154; Fosun 833-291-9645

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2 mg/mL, 10 mL vial (NDC 70860-652-10) Unavailable Distributed by Athenex Pharmaceutical. To contact: 855-273-0154.
2 mg/mL, 20 mL vial (NDC 70860-652-20) Unavailable Distributed by Athenex Pharmaceutical. To contact: 855-273-0154.
2 mg/mL, 10 mL vial (NDC 72266-146-10) Available Distributed by Fosun Pharma. To contact: 866-611-3762
2 mg/mL, 20 mL vial (NDC 72266-147-10) Available Distributed by Fosun Pharma. To contact: 866-611-3762

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Revised 05/12/2020)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2 mg/mL, 10 mL vial (NDC 0143-9506-10) This presentation is temporarily on backorder Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. Demand increase for the drug
2 mg/mL, 20 mL vial (NDC 0143-9507-10) This presentation is temporally on backorder. Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. Demand increase for the drug
2 mg/mL, 10 mL vial (NDC 0143-9310-10), Novaplus TBD
2 mg/mL, 20 mL vial (NDC 0143-9311-10), Novaplus TBD

Hospira, Inc. (Revised 05/15/2020)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Amidate, 2 mg/mL, 20 mL vial (NDC 0409-6695-02) Limited Supply Available. Next delivery and estimated recovery: May 2020 Please check with your wholesaler for available inventory Demand increase for the drug
Amidate, 2 mg/mL, 20 mL syringe (NDC 0409-8060-29) Discontinued

Link to Discontinuance

Discontinuation of the manufacture of the drug

Mylan Institutional (Reverified 05/01/2020)

Company Contact Information:
800-RXMYLAN (1-800-796-9526)

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2 mg/mL, 10 mL vial (NDC 67457-902-10) Supply interruption Other
2 mg/mL, 20 mL vial (NDC 67457-903-20) Available

Pfizer Pharmaceuticals (Revised 05/20/2020)

Company Contact Information:
800-533-4535

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Amidate, 2 mg/mL, 10 mL vial (NDC 0409-6695-01) Limited Supply Available. Next Delivery and Estimated Recovery: May 2020 Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English